We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$52.9B
AUM Growth
-$871M
Cap. Flow
-$306M
Cap. Flow %
-0.58%
Top 10 Hldgs %
10.68%
Holding
4,294
New
780
Increased
1,199
Reduced
1,223
Closed
1,034

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$412M
2
PFE icon
Pfizer
PFE
+$283M
3
DVN icon
Devon Energy
DVN
+$194M
4
VLO icon
Valero Energy
VLO
+$187M
5
MO icon
Altria Group
MO
+$174M

Sector Composition

Rank Sector Weight
1 Healthcare 15.04%
2 Energy 12.07%
3 Financials 9.11%
4 Consumer Discretionary 8.85%
5 Industrials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SA
2526
Seabridge Gold
SA
$3.69B
$596K ﹤0.01%
97,550
-46,348
-32% -$291K
VCRA
2527
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$596K ﹤0.01%
52,068
+11,207
+27% +$124K
BT
2528
DELISTED
BT Group plc (ADR)
BT
$596K ﹤0.01%
16,802
-5,950
-26% -$208K
CYBX
2529
DELISTED
CYBERONICS INC
CYBX
$595K ﹤0.01%
10,000
-246,877
-96% -$15.5M
TG icon
2530
Tredegar Corp
TG
$271M
$594K ﹤0.01%
26,864
-15,443
-37% -$324K
CCXI
2531
DELISTED
ChemoCentryx, Inc.
CCXI
$594K ﹤0.01%
72,146
-51,507
-42% -$409K
NNA
2532
DELISTED
Navios Maritime Acquisition Corporation
NNA
$593K ﹤0.01%
11,008
+10,133
+1,158% +$560K
FOXF icon
2533
Fox Factory Holding Corp
FOXF
$885M
$592K ﹤0.01%
36,844
-9,269
-20% -$149K
UTIW
2534
DELISTED
UTI WORLDWIDE INC
UTIW
$592K ﹤0.01%
59,218
-275,626
-82% -$2.66M
ISSI
2535
DELISTED
INTEGRATED SILICON SOLUTN INC
ISSI
$591K ﹤0.01%
+26,700
New +$529K
TBPH icon
2536
Theravance Biopharma
TBPH
$884M
$590K ﹤0.01%
45,331
-5,165
-10% -$80.1K
TRUE
2537
DELISTED
TrueCar
TRUE
$590K ﹤0.01%
49,168
+29,565
+151% +$426K
VECO icon
2538
Veeco
VECO
$2.82B
$590K ﹤0.01%
+20,532
New +$630K
BPT
2539
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$589K ﹤0.01%
9,538
+4,338
+83% +$287K
IWV icon
2540
iShares Russell 3000 ETF
IWV
$20.2B
$589K ﹤0.01%
4,750
-1,665
-26% -$210K
WABC icon
2541
Westamerica Bancorp
WABC
$1.34B
$589K ﹤0.01%
+11,626
New +$535K
IHF icon
2542
iShares US Healthcare Providers ETF
IHF
$1.24B
$588K ﹤0.01%
20,550
-6,815
-25% -$185K
QUOT
2543
DELISTED
Quotient Technology Inc
QUOT
$587K ﹤0.01%
54,444
+7,294
+15% +$91.3K
WAC
2544
DELISTED
Walter Investment Mgt Corp
WAC
$585K ﹤0.01%
25,585
+7,653
+43% +$146K
UAA icon
2545
Under Armour
UAA
$2.21B
$584K ﹤0.01%
+14,000
New +$566K
CRAI icon
2546
CRA International
CRAI
$1.07B
$583K ﹤0.01%
+20,905
New +$612K
BPTH
2547
DELISTED
Bio-Path Holdings Inc
BPTH
$583K ﹤0.01%
+127
New +$694K
CTG
2548
DELISTED
Computer Task Group, Inc.
CTG
$582K ﹤0.01%
75,347
+36,439
+94% +$283K
IJT icon
2549
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.19B
$578K ﹤0.01%
+8,828
New +$576K
NVGS icon
2550
Navigator Holdings
NVGS
$1.32B
$578K ﹤0.01%
30,500
-2,565
-8% -$52.2K

Similar funds

Israel Englander's Q2 2015 Portfolio in Review

As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.

  • Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
  • Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
  • Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
  • Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
  • Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
  • Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
  • Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.

Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.